Physician profile
Lorraine E Weaver
NPI 1164466520
$1,180.60
in general payments reported to CMS, 2019-2025
19 companies · $153 in 2025
The $153 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2020: $101 · 2021: $209 · 2022: $93.47 · 2023: $308 · 2024: $192 · 2025: $153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $653.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $653.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $217.79 | 2019-2024 | Lo Loestrin Fe |
| Aspira Women'S Health INC | $165.47 | 2023-2024 | Ova1 |
| Coopersurgical, INC. | $149.33 | 2020-2025 | Paragard T 380a, Cook |
| Sumitomo Pharma America, INC. | $116.07 | 2023-2025 | Myfembree |
| Hologic Sales and Service, LLC | $110.23 | 2020-2025 | Aptima, Acessa Provu System, Novasure |
| Exeltis, USA INC. | $71.50 | 2021-2025 | Slynd |
| Astellas Pharma US INC | $69.91 | 2023-2024 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $54.78 | 2021-2024 | |
| Kci USA, INC. | $29.35 | 2021 | |
| Amag Pharmaceuticals, INC. | $26.70 | 2019 | |
| Davol INC. | $25.16 | 2019 | |
| Therapeuticsmd, INC. | $23.95 | 2021-2022 | |
| Biogen, INC. | $21.71 | 2025 | Zurzuvae |
| Myovant Sciences INC. | $21.39 | 2022 | |
| Pfizer INC. | $20.16 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $17.14 | 2021 | |
| Allergan, INC. | $14.93 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $13.79 | 2023 | Seglentis |
| Ethicon US, LLC | $11.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lorraine Weaver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.